Ronald M. Kudla, Ph.D., MBA, CLP currently serves as the executive director of intellectual property, technology transfer, and new ventures at Rensselaer Polytechnic Institute. Kudla oversees the strategic development, protection, marketing, and licensing of promising innovations arising from the Institute’s research activities. He reports to Chief of Staff and Associate Vice President for Policy and Planning in the President’s Office.

In his most recent position as director of academic liaison for North America within the Genetics and Discovery Alliances Group at GlaxoSmithKline, he was responsible for establishing strategic research alliances, consortium agreements, technology in-licensing agreements, multi-year research grants, consulting relationships, material transfer agreements, and new technology assessments with North American universities and government research entities.

Kudla previously served as the director of the Office of Technology Licensing at the University of Florida, and director of patents and licensing at the Wisconsin Alumni Research Foundation (WARF) in Madison, Wisconsin. Kudla also has extensive experience in product development in the pharmaceutical industry. He served as the Director of Licensing and Business Development for G.D. Searle Inc. and Director of Worldwide Product Development. At Lederle Laboratories, Dr. Kudla served as the Manager of International Medical Product Development.